Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Clinical case reports ; 11(2), 2023.
Article in English | EuropePMC | ID: covidwho-2248317

ABSTRACT

In this communication, we reported a series of six patients presented with Guillain‐Barré syndrome that associated with COVID‐19 infection, which was confirmed with RT‐PCR. Here we discuss the laboratory investigation and case management, as well as clinical presentation and outcome of each case. The current report demonstrated the first case series of COVID‐19‐associated GBS‐cases in Sudan.

2.
Trans R Soc Trop Med Hyg ; 115(4): 397-405, 2021 04 14.
Article in English | MEDLINE | ID: covidwho-2274935

ABSTRACT

Mycetoma is a chronic disease caused either by fungi (eumycetoma) or bacteria (actinomycetoma). Treatment remains suboptimal and based on personal clinical experience. Recently, the Mycetoma Research Centre (MRC), a WHO Collaborating Centre on mycetoma, began the first-ever double-blind clinical trial. Here, we report the challenges and barriers faced in the recruitment and retention of patients in the MRC experience. Patient recruitment and retention are critical determinants of clinical trial success and yet a substantial number of trials fail to reach their recruitment goals. Recruitment challenges are identified throughout the different stages of the clinical trial, starting from planning, participant screening and intervention, through to retaining participants for the entire study duration. The MRC made efforts to address these challenges to ensure the constant flow of patients. The recruitment committee at the MRC conducted training workshops for the medical staff in the endemic areas, along with regular meetings with health authorities and local leaders. Moreover, telemedicine technology was used to examine patients in endemic areas. Challenges and barriers facing clinical trial conduct need to be examined thoroughly to ensure actionable, evidence-based recommendations for improving patient recruitment and retention. In conclusion, effective patient recruitment and retention are based on three pillars, which are proper clinical trial design and protocol development, realistic and feasible trial site selection, and objective communication with the trial stakeholders.


Subject(s)
Mycetoma , Developing Countries , Double-Blind Method , Humans , Mycetoma/therapy , Patient Selection
3.
Clin Case Rep ; 11(2): e6988, 2023 Feb.
Article in English | MEDLINE | ID: covidwho-2248316

ABSTRACT

In this communication, we reported a series of six patients presented with Guillain-Barré syndrome that associated with COVID-19 infection, which was confirmed with RT-PCR. Here we discuss the laboratory investigation and case management, as well as clinical presentation and outcome of each case. The current report demonstrated the first case series of COVID-19-associated GBS-cases in Sudan.

4.
Inf Better World (2022) ; 13193: 332-346, 2022.
Article in English | MEDLINE | ID: covidwho-1750598

ABSTRACT

Multiple symptom tracking applications (apps) were created during the early phase of the COVID-19 pandemic. While they provided crowdsourced information about the state of the pandemic in a scalable manner, they also posed significant privacy risks for individuals. The present study investigates the interplay between individual privacy attitudes and the adoption of symptom tracking apps. Using the communication privacy theory as a framework, it studies how users' privacy attitudes changed during the public health emergency compared to the pre-COVID times. Based on focus-group interviews (N=21), this paper reports significant changes in users' privacy attitudes toward such apps. Research participants shared various reasons for both increased acceptability (e.g., disease uncertainty, public good) and decreased acceptability (e.g., reduced utility due to changed lifestyle) during COVID. The results of this study can assist health informatics researchers and policy designers in creating more socially acceptable health apps in the future.

5.
J Infect Dev Ctries ; 15(11): 1615-1617, 2021 Nov 30.
Article in English | MEDLINE | ID: covidwho-1572706

ABSTRACT

The impacts of COVID -19 pandemic have been quite significant on healthcare providers. I was particularly challenging for those in Low and Middle-Income Countries including Sudan . Unfortunately, the pandemic has hit Sudan on extremely difficult time for the country and its people. The country was coming out of long-brutal and devastating dictatorship and transitioning to new democracy with civilian leadership. In addition to the pandemic related issues, trying to rebuild the health system during socioeconomic crisis, healthcare providers  in the country were challenged personally and professionally. These challenges include the stress of working in under-resourced settings with limited access to personal-protection equipment and testing kits raised the fear of contracting the virus and spreading it to their families. The professional, social, and personal life of healthcare providers have been dramatically changed by the ongoing pandemic, however, they are heroically accepting this change in a hope that, this will save the life of many more people. Nevertheless, their fights and sacrifices should at least be rewarded by governments and communities altogether strictly enforce the implementation of other preventive measures including vaccination, face masking, and social distancing and get all protected. We should all understand that, unless we are all protected no one is protected, so all must adapt to the new norm of life and collaborate not only on ending this pandemic but to prevent similar ones in the future.


Subject(s)
COVID-19/prevention & control , Health Personnel , Occupational Diseases/prevention & control , SARS-CoV-2 , COVID-19/epidemiology , Humans , Occupational Diseases/epidemiology , Pandemics , Personal Protective Equipment , Sudan/epidemiology , Vaccination
7.
J Infect Dev Ctries ; 15(2): 204-208, 2021 03 07.
Article in English | MEDLINE | ID: covidwho-1150799

ABSTRACT

The steadily growing COVID-19 pandemic is challenging health systems worldwide including Sudan. In Sudan, the first COVID-19 case was reported on 13th March 2020, and up to 11 November 2020 there were 14,401 confirmed cases of which 9,535 cases recovered and the rest 3,750 cases were under treatment. Additionally, 1,116 deaths were reported, indicating a relatively high case fatality rate of 7.7%. Several preventive and control measures were implemented by the government of Sudan and health partners, including the partial lockdown of the country, promoting social distancing, and suspending mass gathering such as festivals and performing religious practices in groups. However, new cases still emerging every day and this could be attributed to the noncompliance of the individuals to the advocated preventive measurements.


Subject(s)
COVID-19/epidemiology , COVID-19/transmission , Communicable Disease Control/methods , Africa/epidemiology , COVID-19/mortality , COVID-19/prevention & control , Communicable Disease Control/organization & administration , Humans , Mass Media , Mortality , Socioeconomic Factors , Sudan/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL